Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing | ||
| dc.conicet.organizacion | Karolinska Huddinge Hospital. Karolinska Institutet | |
| dc.conicet.organizacion | Swedish Institute for Communicable Disease Control | |
| dc.conicet.organizacion | Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo" | |
| dc.conicet.organizacion | Karolinska Huddinge Hospital. Karolinska Institutet | |
| dc.conicet.organizacion | Swedish Institute for Communicable Disease Control | |
| dc.conicet.organizacion | Karolinska Huddinge Hospital. Karolinska Institutet | |
| dc.conicet.organizacion | Swedish Institute for Communicable Disease Control | |
| dc.contributor.author | Engström, Anna | |
| dc.contributor.author | Morcillo, Nora Susana | |
| dc.contributor.author | Imperiale, Belén Rocío | |
| dc.contributor.author | Hoffner, Sven E. | |
| dc.contributor.author | Juréen, Pontus | |
| dc.date.issued | 2012-06 | |
| dc.description.abstract | Conventional phenotypic drug susceptibility testing (DST) methods for Mycobacterium tuberculosis are laborious and very time-consuming. Early detection of drug-resistant tuberculosis (TB) is essential for prevention and control of TB transmission. We have developed a pyrosequencing method for simultaneous detection of mutations associated with resistance to rifampin, isoniazid, ethambutol, amikacin, kanamycin, capreomycin, and ofloxacin. Seven pyrosequencing assays were optimized for following loci: rpoB, katG, embB, rrs, gyrA, and the promoter regions of inhA and eis. The molecular method was evaluated on a panel of 290 clinical isolates of M. tuberculosis. In comparison to phenotypic DST, the pyrosequencing method demonstrated high specificity (100%) and sensitivity (94.6%) for detection of multidrug-resistant M. tuberculosis as well as high specificity (99.3%) and sensitivity (86.9%) for detection of extensively drug-resistant M. tuberculosis. The short turnaround time combined with multilocus sequencing of several isolates in parallel makes pyrosequencing an attractive method for drug resistance screening in M. tuberculosis. | es |
| dc.description.fil | Fil: Engström, Anna. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia. Swedish Institute for Communicable Disease Control; Suecia | |
| dc.description.fil | Fil: Morcillo, Nora Susana. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina | |
| dc.description.fil | Fil: Imperiale, Belén Rocío. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina | |
| dc.description.fil | Fil: Hoffner, Sven E.. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia. Swedish Institute for Communicable Disease Control; Suecia | |
| dc.description.fil | Fil: Juréen, Pontus. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia. Swedish Institute for Communicable Disease Control; Suecia | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Engström, Anna; Morcillo, Nora Susana; Imperiale, Belén Rocío; Hoffner, Sven E.; Juréen, Pontus; Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing; American Society for Microbiology; Journal of Clinical Microbiology; 50; 6; 6-2012; 2026-2033 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0095-1137 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/192466 | |
| dc.journal.ciudad | Washington D.C | es |
| dc.journal.number | 6 | es |
| dc.journal.pagination | 2026-2033 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Journal of Clinical Microbiology | es |
| dc.journal.volume | 50 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Society for Microbiology | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://journals.asm.org/doi/10.1128/JCM.06664-11 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1128/JCM.06664-11 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | MYCOBACTERIUM TUBERCULOSIS | es |
| dc.subject | PYROSEQUENCING | es |
| dc.subject | DRUG RESISTANCE | es |
| dc.subject | FIRST AND SECOND LINE DRUGS | es |
| dc.subject.classification | Biología Celular, Microbiología | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.38955c19-657c-4a95-9748-580331c89a96_B.pdf
- Tamaño:
- 239.32 KB
- Formato:
- Adobe Portable Document Format